Nasdaq · USD
KNSA
Sign in to followKiniksa Pharmaceuticals International, plc
Export transactions ↓Last 12 months
Inside the activity.
0 purchase rows · 37 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 7 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 12 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2024 Filed Apr 3, 2024 21:25 UTC |
Ragosa MarkCHIEF FINANCIAL OFFICER
|
Tax withholdingClass A Common Share | 514 | $19.70 | $10,125.80 |
DisclosureSEC source: 0001415889-24-010091 · form4-04032024_090446.xml · nonDerivative · entry 2 Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,868 Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:25 UTC |
Ragosa MarkCHIEF FINANCIAL OFFICER
|
Exercise / conversionClass A Common Share | 1,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-010091 · form4-04032024_090446.xml · nonDerivative · entry 1 Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:23 UTC |
Tessari EbenCHIEF OPERATING OFFICER
|
Exercise / conversionRestricted Share Unit · Derivative | 1,773 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010088 · form4-04032024_090445.xml · derivative · entry 3 Tessari Eben · CIK 0001867899 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,318 Underlying: Class A Common Share · 1,773 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. F2 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, April 1, 2023. F2 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, April 1, 2023. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:23 UTC |
Tessari EbenCHIEF OPERATING OFFICER
|
Tax withholdingClass A Common Share | 521 | $19.70 | $10,263.70 |
DisclosureSEC source: 0001415889-24-010088 · form4-04032024_090445.xml · nonDerivative · entry 2 Tessari Eben · CIK 0001867899 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,099 Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:23 UTC |
Tessari EbenCHIEF OPERATING OFFICER
|
Exercise / conversionClass A Common Share | 1,773 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-010088 · form4-04032024_090445.xml · nonDerivative · entry 1 Tessari Eben · CIK 0001867899 · CHIEF OPERATING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,620 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:22 UTC |
Patel Sanj KDirector · CHAIRMAN & CEO
|
Exercise / conversionRestricted Share Unit · Derivative | 6,482 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010086 · form4-04032024_090440.xml · derivative · entry 4 Patel Sanj K · CIK 0001532218 · Director · CHAIRMAN & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,443 Underlying: Class A Common Share · 6,482 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. F2 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 1, 2023. F2 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 1, 2023. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:22 UTC |
Patel Sanj KDirector · CHAIRMAN & CEO
|
Tax withholdingClass A Common Share | 1,903 | $19.70 | $37,489.10 |
DisclosureSEC source: 0001415889-24-010086 · form4-04032024_090440.xml · nonDerivative · entry 2 Patel Sanj K · CIK 0001532218 · Director · CHAIRMAN & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,095 Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:22 UTC |
Patel Sanj KDirector · CHAIRMAN & CEO
|
Exercise / conversionClass A Common Share | 6,482 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-010086 · form4-04032024_090440.xml · nonDerivative · entry 1 Patel Sanj K · CIK 0001532218 · Director · CHAIRMAN & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,998 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:21 UTC |
Megna Michael RCHIEF ACCOUNTING OFFICER
|
Exercise / conversionRestricted Share Unit · Derivative | 2,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010084 · form4-04032024_090431.xml · derivative · entry 3 Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,672 Underlying: Class A Common Share · 2,558 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. F2 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, April 1, 2023. F2 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, April 1, 2023. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:21 UTC |
Megna Michael RCHIEF ACCOUNTING OFFICER
|
Tax withholdingClass A Common Share | 1,084 | $19.70 | $21,354.80 |
DisclosureSEC source: 0001415889-24-010084 · form4-04032024_090431.xml · nonDerivative · entry 2 Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,062 Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:21 UTC |
Megna Michael RCHIEF ACCOUNTING OFFICER
|
Exercise / conversionClass A Common Share | 2,558 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-010084 · form4-04032024_090431.xml · nonDerivative · entry 1 Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,146 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:20 UTC |
Moat RossCHIEF COMMERCIAL OFFICER
|
Exercise / conversionRestricted Share Unit · Derivative | 1,612 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010079 · form4-04032024_090405.xml · derivative · entry 3 Moat Ross · CIK 0001857177 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,833 Underlying: Class A Common Share · 1,612 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. F2 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, April 1, 2023. F2 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, April 1, 2023. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:20 UTC |
Moat RossCHIEF COMMERCIAL OFFICER
|
Tax withholdingClass A Common Share | 880 | $19.70 | $17,336.00 |
DisclosureSEC source: 0001415889-24-010079 · form4-04032024_090405.xml · nonDerivative · entry 2 Moat Ross · CIK 0001857177 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,152 Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:20 UTC |
Moat RossCHIEF COMMERCIAL OFFICER
|
Exercise / conversionClass A Common Share | 1,612 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-010079 · form4-04032024_090405.xml · nonDerivative · entry 1 Moat Ross · CIK 0001857177 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,032 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:18 UTC |
Paolini John F.CHIEF MEDICAL OFFICER
|
Exercise / conversionRestricted Share Unit · Derivative | 1,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010077 · form4-04032024_090447.xml · derivative · entry 3 Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,872 Underlying: Class A Common Share · 1,624 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. F2 · derivative.exercise_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, April 1, 2023. F2 · derivative.expiration_date: The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date, April 1, 2023. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:18 UTC |
Paolini John F.CHIEF MEDICAL OFFICER
|
Tax withholdingClass A Common Share | 477 | $19.70 | $9,396.90 |
DisclosureSEC source: 0001415889-24-010077 · form4-04032024_090447.xml · nonDerivative · entry 2 Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,039 Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:18 UTC |
Paolini John F.CHIEF MEDICAL OFFICER
|
Exercise / conversionClass A Common Share | 1,624 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-010077 · form4-04032024_090447.xml · nonDerivative · entry 1 Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,516 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 23:05 UTC |
Patel Sanj KDirector · CHAIRMAN & CEO
|
SaleClass A Common Share | 65,012 | $21.02 | $1,366,552.24 |
DisclosureSEC source: 0001415889-24-007569 · form4-03112024_110346.xml · nonDerivative · entry 1 Patel Sanj K · CIK 0001532218 · Director · CHAIRMAN & CEO 10b5-1 filing: Plan reported Ownership: Indirect · Held by The Anglia 2013 Revocable Trust, u/d/t August 15, 2013 Disclosed balance after: 0 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $21.00 and $21.145. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| March 06, 2024 Filed Mar 6, 2024 22:37 UTC |
Patel Sanj KDirector · CHAIRMAN & CEO
|
SaleClass A Common Share | 5,582 | $21.00 | $117,222.00 |
DisclosureSEC source: 0001415889-24-007083 · form4-03062024_100330.xml · nonDerivative · entry 3 Patel Sanj K · CIK 0001532218 · Director · CHAIRMAN & CEO 10b5-1 filing: Plan reported Ownership: Indirect · Held by The Anglia 2013 Revocable Trust, u/d/t August 15, 2013 Disclosed balance after: 65,012 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 22:37 UTC |
Patel Sanj KDirector · CHAIRMAN & CEO
|
SaleClass A Common Share | 3,336 | $22.00 | $73,392.00 |
DisclosureSEC source: 0001415889-24-007083 · form4-03062024_100330.xml · nonDerivative · entry 2 Patel Sanj K · CIK 0001532218 · Director · CHAIRMAN & CEO 10b5-1 filing: Plan reported Ownership: Indirect · Held by The Anglia 2013 Revocable Trust, u/d/t August 15, 2013 Disclosed balance after: 70,594 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 22:37 UTC |
Patel Sanj KDirector · CHAIRMAN & CEO
|
SaleClass A Common Share | 9,406 | $21.31 | $200,441.86 |
DisclosureSEC source: 0001415889-24-007083 · form4-03062024_100330.xml · nonDerivative · entry 1 Patel Sanj K · CIK 0001532218 · Director · CHAIRMAN & CEO 10b5-1 filing: Plan reported Ownership: Indirect · Held by The Anglia 2013 Revocable Trust, u/d/t August 15, 2013 Disclosed balance after: 73,930 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $21.00 and $21.785. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| March 01, 2024 Filed Mar 1, 2024 23:26 UTC |
Megna Michael RCHIEF ACCOUNTING OFFICER
|
Exercise / conversionShare Option · Derivative | 4,014 | $0.00 Strike: $13.88 | $0.00 |
DisclosureSEC source: 0001415889-24-006170 · form4-03012024_110310.xml · derivative · entry 9 Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Share · 4,014 shares Expires 2028-08-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023. F5 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| March 01, 2024 Filed Mar 1, 2024 23:26 UTC |
Megna Michael RCHIEF ACCOUNTING OFFICER
|
Exercise / conversionShare Option · Derivative | 5,645 | $0.00 Strike: $8.83 | $0.00 |
DisclosureSEC source: 0001415889-24-006170 · form4-03012024_110310.xml · derivative · entry 8 Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 229 Underlying: Class A Common Share · 5,645 shares Expires 2029-09-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023. F5 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| March 01, 2024 Filed Mar 1, 2024 23:26 UTC |
Megna Michael RCHIEF ACCOUNTING OFFICER
|
SaleClass A Common Share | 9,659 | $21.45 | $207,185.55 |
DisclosureSEC source: 0001415889-24-006170 · form4-03012024_110310.xml · nonDerivative · entry 6 Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,588 F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023. F4 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $21.45 to $21.49. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| March 01, 2024 Filed Mar 1, 2024 23:26 UTC |
Megna Michael RCHIEF ACCOUNTING OFFICER
|
Exercise / conversionClass A Common Share | 4,014 | $13.88 | $55,714.32 |
DisclosureSEC source: 0001415889-24-006170 · form4-03012024_110310.xml · nonDerivative · entry 5 Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,247 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023. Read SEC document |
| March 01, 2024 Filed Mar 1, 2024 23:26 UTC |
Megna Michael RCHIEF ACCOUNTING OFFICER
|
Exercise / conversionClass A Common Share | 5,645 | $8.83 | $49,845.35 |
DisclosureSEC source: 0001415889-24-006170 · form4-03012024_110310.xml · nonDerivative · entry 4 Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:34 UTC |
Tessari EbenCHIEF OPERATING OFFICER
|
Exercise / conversionShare Option · Derivative | 656 | $0.00 Strike: $1.59 | $0.00 |
DisclosureSEC source: 0001415889-24-006702 · form4-03052024_090322.xml · derivative · entry 3 Tessari Eben · CIK 0001867899 · CHIEF OPERATING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,017 Underlying: Class A Common Share · 656 shares Expires 2025-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on March 4, 2022. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:34 UTC |
Tessari EbenCHIEF OPERATING OFFICER
|
SaleClass A Common Share | 1,189 | $22.03 | $26,193.67 |
DisclosureSEC source: 0001415889-24-006702 · form4-03052024_090322.xml · nonDerivative · entry 2 Tessari Eben · CIK 0001867899 · CHIEF OPERATING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 122,847 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on March 4, 2022. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging between $22.03 and $22.055. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:34 UTC |
Tessari EbenCHIEF OPERATING OFFICER
|
Exercise / conversionClass A Common Share | 656 | $1.59 | $1,043.04 |
DisclosureSEC source: 0001415889-24-006702 · form4-03052024_090322.xml · nonDerivative · entry 1 Tessari Eben · CIK 0001867899 · CHIEF OPERATING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,036 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on March 4, 2022. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:31 UTC |
Paolini John F.CHIEF MEDICAL OFFICER
|
Exercise / conversionShare Option · Derivative | 18,844 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001415889-24-006674 · form4-03052024_090325.xml · derivative · entry 3 Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 82,217 Underlying: Class A Common Shares · 18,844 shares Expires 2026-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:31 UTC |
Paolini John F.CHIEF MEDICAL OFFICER
|
SaleClass A Common Share | 18,844 | $21.77 | $410,233.88 |
DisclosureSEC source: 0001415889-24-006674 · form4-03052024_090325.xml · nonDerivative · entry 2 Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,892 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $21.21 to $22.07. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:31 UTC |
Paolini John F.CHIEF MEDICAL OFFICER
|
Exercise / conversionClass A Common Share | 18,844 | $1.86 | $35,049.84 |
DisclosureSEC source: 0001415889-24-006674 · form4-03052024_090325.xml · nonDerivative · entry 1 Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,736 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 23:26 UTC |
Megna Michael RCHIEF ACCOUNTING OFFICER
|
Exercise / conversionShare Option · Derivative | 5,126 | $0.00 Strike: $8.83 | $0.00 |
DisclosureSEC source: 0001415889-24-006170 · form4-03012024_110310.xml · derivative · entry 7 Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,874 Underlying: Class A Common Share · 5,126 shares Expires 2029-09-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023. F5 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 23:26 UTC |
Megna Michael RCHIEF ACCOUNTING OFFICER
|
SaleClass A Common Share | 5,126 | $21.79 | $111,695.54 |
DisclosureSEC source: 0001415889-24-006170 · form4-03012024_110310.xml · nonDerivative · entry 3 Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,588 F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023. F3 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $21.56 to $21.90. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 23:26 UTC |
Megna Michael RCHIEF ACCOUNTING OFFICER
|
Exercise / conversionClass A Common Share | 5,126 | $8.83 | $45,262.58 |
DisclosureSEC source: 0001415889-24-006170 · form4-03012024_110310.xml · nonDerivative · entry 2 Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,714 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:26 UTC |
Paolini John F.CHIEF MEDICAL OFFICER
|
Exercise / conversionShare Option · Derivative | 10,156 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001415889-24-005883 · form4-02292024_090213.xml · derivative · entry 3 Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 101,061 Underlying: Class A Common Shares · 10,156 shares Expires 2026-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:26 UTC |
Paolini John F.CHIEF MEDICAL OFFICER
|
SaleClass A Common Share | 10,156 | $21.03 | $213,580.68 |
DisclosureSEC source: 0001415889-24-005883 · form4-02292024_090213.xml · nonDerivative · entry 2 Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,892 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $21.00 to $21.09. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 21:26 UTC |
Paolini John F.CHIEF MEDICAL OFFICER
|
Exercise / conversionClass A Common Share | 10,156 | $1.86 | $18,890.16 |
DisclosureSEC source: 0001415889-24-005883 · form4-02292024_090213.xml · nonDerivative · entry 1 Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,048 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023. Read SEC document |
| January 15, 2024 Filed Mar 1, 2024 23:26 UTC |
Megna Michael RCHIEF ACCOUNTING OFFICER
|
GrantClass A Common Share | 583 | $12.35 | $7,200.05 |
DisclosureSEC source: 0001415889-24-006170 · form4-03012024_110310.xml · nonDerivative · entry 1 Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,588 F1 · kind: The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of July 16, 2023 to January 15, 2024. The acquisition of such shares was exempt pursuant to Rule 16b-3(c). Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 21:30 UTC |
Ragosa MarkCHIEF FINANCIAL OFFICER
|
Exercise / conversionShare Option · Derivative | 12,000 | $0.00 Strike: $8.83 | $0.00 |
DisclosureSEC source: 0001415889-24-000609 · form4-01042024_040113.xml · derivative · entry 3 Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Share · 12,000 shares Expires 2029-09-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on August 22, 2023. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 21:30 UTC |
Ragosa MarkCHIEF FINANCIAL OFFICER
|
SaleClass A Common Share | 12,000 | $20.00 | $240,000.00 |
DisclosureSEC source: 0001415889-24-000609 · form4-01042024_040113.xml · nonDerivative · entry 2 Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,632 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on August 22, 2023. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 21:30 UTC |
Ragosa MarkCHIEF FINANCIAL OFFICER
|
Exercise / conversionClass A Common Share | 12,000 | $8.83 | $105,960.00 |
DisclosureSEC source: 0001415889-24-000609 · form4-01042024_040113.xml · nonDerivative · entry 1 Ragosa Mark · CIK 0001835458 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,632 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on August 22, 2023. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:30 UTC |
Megna Michael RCHIEF ACCOUNTING OFFICER
|
Exercise / conversionShare Option · Derivative | 16,670 | $0.00 Strike: $13.88 | $0.00 |
DisclosureSEC source: 0001415889-24-000608 · form4-01042024_040110.xml · derivative · entry 3 Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,014 Underlying: Class A Common Share · 16,670 shares Expires 2028-08-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:30 UTC |
Megna Michael RCHIEF ACCOUNTING OFFICER
|
SaleClass A Common Share | 16,670 | $19.17 | $319,563.90 |
DisclosureSEC source: 0001415889-24-000608 · form4-01042024_040110.xml · nonDerivative · entry 2 Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,005 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023. F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $19.13 to $19.43. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:30 UTC |
Megna Michael RCHIEF ACCOUNTING OFFICER
|
Exercise / conversionClass A Common Share | 16,670 | $13.88 | $231,379.60 |
DisclosureSEC source: 0001415889-24-000608 · form4-01042024_040110.xml · nonDerivative · entry 1 Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,675 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023. Read SEC document |
| December 19, 2023 Filed Dec 21, 2023 21:26 UTC |
Megna Michael RCHIEF ACCOUNTING OFFICER
|
Exercise / conversionShare Option · Derivative | 9,316 | $0.00 Strike: $13.88 | $0.00 |
DisclosureSEC source: 0001415889-23-016827 · form4-12212023_091222.xml · derivative · entry 3 Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,684 Underlying: Class A Common Share · 9,316 shares Expires 2028-08-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| December 19, 2023 Filed Dec 21, 2023 21:26 UTC |
Megna Michael RCHIEF ACCOUNTING OFFICER
|
SaleClass A Common Share | 9,316 | $19.13 | $178,215.08 |
DisclosureSEC source: 0001415889-23-016827 · form4-12212023_091222.xml · nonDerivative · entry 2 Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,005 Read SEC document |
| December 19, 2023 Filed Dec 21, 2023 21:26 UTC |
Megna Michael RCHIEF ACCOUNTING OFFICER
|
Exercise / conversionClass A Common Share | 9,316 | $13.88 | $129,306.08 |
DisclosureSEC source: 0001415889-23-016827 · form4-12212023_091222.xml · nonDerivative · entry 1 Megna Michael R · CIK 0001464583 · CHIEF ACCOUNTING OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,321 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023. Read SEC document |
| December 07, 2023 Filed Dec 11, 2023 21:20 UTC |
Paolini John F.CHIEF MEDICAL OFFICER
|
Exercise / conversionShare Option · Derivative | 28,600 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001415889-23-016183 · form4-12112023_041201.xml · derivative · entry 6 Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 111,217 Underlying: Class A Common Shares · 28,600 shares Expires 2026-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023. F6 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| December 07, 2023 Filed Dec 11, 2023 21:20 UTC |
Paolini John F.CHIEF MEDICAL OFFICER
|
SaleClass A Common Share | 1,501 | $17.81 | $26,732.81 |
DisclosureSEC source: 0001415889-23-016183 · form4-12112023_041201.xml · nonDerivative · entry 5 Paolini John F. · CIK 0001741533 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,892 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023. F5 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $17.80 to $17.82. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.